{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T09:32:14Z","timestamp":1649151134069},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.rce.2014.07.012","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T12:50:08Z","timestamp":1414846208000},"page":"33-42","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novedades cardiovasculares 2013\/2014"],"prefix":"10.1016","volume":"215","author":[{"given":"J.I.","family":"Cuende","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lahoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Armario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Garc\u00eda-Alegr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Garc\u00eda de Casasola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Mostaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2014.07.012_bib0005","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.recesp.2011.05.033","article-title":"Analyzing the coronary heart disease mortality decline in a Mediterranean population: Spain 1988-2005","volume":"64","author":"Flores-Mateo","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.rce.2014.07.012_bib0010","first-page":"848","article-title":"Contributions of cardiovascular mortality to Spanish life expectancy from 1980 to 2009","volume":"66","author":"Garc\u00eda-Gonz\u00e1lez","year":"2013","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.rce.2014.07.012_bib0015","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.rce.2011.05.019","article-title":"2010: \u00bfQu\u00e9 ha habido de nuevo en riesgo vascular?","volume":"211","author":"\u00c1lvarez-Sala Walther","year":"2011","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2014.07.012_bib0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.rce.2013.06.009","article-title":"\u00bfQu\u00e9 ha habido de nuevo en riesgo vascular en el a\u00f1o 2012?","volume":"213","author":"S\u00e1nchez Fuentes","year":"2013","journal-title":"Rev Clin Esp"},{"issue":"25 Suppl 2","key":"10.1016\/j.rce.2014.07.012_bib0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"25 Suppl 2","key":"10.1016\/j.rce.2014.07.012_bib0030","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"25 Suppl 2","key":"10.1016\/j.rce.2014.07.012_bib0035","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1161\/01.cir.0000437740.48606.d1","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Eckel","year":"2014","journal-title":"Circulation"},{"issue":"25 Suppl 2","key":"10.1016\/j.rce.2014.07.012_bib0040","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.rce.2014.07.012_bib0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacl.2013.12.005","article-title":"An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia","volume":"8","author":"Grundy","year":"2014","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.rce.2014.07.012_bib0050","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rce.2014.07.012_bib0055","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/jama.2014.2632","article-title":"Comparison of application of the ACC\/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort","volume":"311","author":"Kavousi","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.rce.2014.07.012_bib0060","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/eurheartj\/ehu064","article-title":"Population and economic impact of the 2013 ACC\/AHA guidelines compared with European guidelines to prevent cardiovascular disease","volume":"35","author":"Vaucher","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rce.2014.07.012_bib0065","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: The Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.rce.2014.07.012_bib0070","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1093\/eurheartj\/ehq205","article-title":"How to calculate vascular age with the SCORE project scales: A new method of cardiovascular risk evaluation","volume":"31","author":"Cuende","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rce.2014.07.012_bib0075","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rce.2014.07.012_bib0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/HJR.0b013e328337ccd3","article-title":"Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles","volume":"17","author":"Soureti","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"10.1016\/j.rce.2014.07.012_bib0085","doi-asserted-by":"crossref","DOI":"10.1177\/2047487313518479","article-title":"Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: A randomized trial","author":"Lopez-Gonzalez","year":"2014","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.rce.2014.07.012_bib0090","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ahj.2008.07.023","article-title":"Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe\/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes","volume":"156","author":"Cannon","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.rce.2014.07.012_bib0095","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2013.06.006","article-title":"HPS2-THRIVE results: Bad for niacin\/laropiprant, good for ezetimibe?","volume":"229","author":"Masana","year":"2013","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.rce.2014.07.012_bib0100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/heartjnl-2013-304678","article-title":"High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: A population-based study","volume":"100","author":"Pauriah","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.rce.2014.07.012_bib0105","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.jacc.2014.03.019","article-title":"Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: The GAUSS-2 randomized. Placebo-controlled phase 3 clinical trial of evolocumab","volume":"63","author":"Stroes","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rce.2014.07.012_bib0110","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1316222","article-title":"A 52-week placebo-controlled trial of evolocumab in hyperlipidemia","volume":"370","author":"Blom","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2014.07.012_bib0115","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jamainternmed.2014.1927","article-title":"Different time trends of caloric and fat intake between statin users and nonusers among US adults: Gluttony in the time of statins?","volume":"174","author":"Sugiyama","year":"2014","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.rce.2014.07.012_bib0120","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardioloy (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.rce.2014.07.012_bib0125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.rce.2014.07.012_bib0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1310753","article-title":"Stenting and medical therapy for atherosclerotic renal-artery stenosis","volume":"370","author":"Cooper","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/jhh.2013.105","article-title":"Salt reduction in the United Kingdom: A successful experiment in public health","volume":"28","author":"He","year":"2014","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.rce.2014.07.012_bib0140","doi-asserted-by":"crossref","first-page":"e8525","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: Nested case-control study","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.rce.2014.07.012_bib0145","doi-asserted-by":"crossref","first-page":"f5680","DOI":"10.1136\/bmj.f5680","article-title":"Blood pressure lowering and major cardiovascular events in people with or without chronic kidney disease: Meta-analysis of randomized controlled trials","volume":"347","author":"Ninomiya","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.rce.2014.07.012_bib0150","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: A meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rce.2014.07.012_bib0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial","volume":"382","author":"Benavente","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rce.2014.07.012_bib0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/HYPERTENSIONAHA.113.02026","article-title":"Refractory hypertension, determination of prevalence, risk factors, and comorbidities in a large, population-based cohort","volume":"63","author":"Calhoun","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.rce.2014.07.012_bib0165","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0170","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa1311386","article-title":"A randomized trial of genotype-guided dosing of warfarin","volume":"369","author":"Pirmohamed","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0175","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa1311388","article-title":"A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon","volume":"369","author":"Verhoef","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rce.2014.07.012_bib0180","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","article-title":"A pharmacogenetic versus a clinical algorithm for warfarin dosing","volume":"369","author":"Kimmel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0185","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jamainternmed.2014.2368","article-title":"Genotype-guided vs clinical dosing of warfarin and its analogues: Meta-analysis of randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0190","doi-asserted-by":"crossref","first-page":"e57661","DOI":"10.1371\/journal.pone.0057661","article-title":"The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in Korean patients","volume":"8","author":"An","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.rce.2014.07.012_bib0195","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rce.2014.07.012_bib0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacc.2013.05.029","article-title":"Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention","volume":"62","author":"Lamberts","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rce.2014.07.012_bib0205","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.113.004834","article-title":"Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: A nationwide cohort study","volume":"129","author":"Lamberts","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.rce.2014.07.012_bib0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0215","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M13-1725","article-title":"Prevention of diabetes with Mediterranean diets: A subgroup analysis of a randomized trial","volume":"160","author":"Salas-Salvad\u00f3","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0225","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia","volume":"369","author":"Crane","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0230","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0235","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rce.2014.07.012_bib0240","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa1401329","article-title":"Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes","volume":"370","author":"Schauer","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256514003488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256514003488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T02:25:52Z","timestamp":1538101552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256514003488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0014256514003488"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2014.07.012","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novedades cardiovasculares 2013\/2014","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2014.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}